| scholarly article | Q13442814 |
| P2093 | author name string | Qin Wang | |
| John R Traynor | |||
| P2860 | cites work | A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers | Q24530081 |
| Galphao/i-stimulated proteosomal degradation of RGS20: a mechanism for temporal integration of Gs and Gi pathways | Q24626665 | ||
| Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells | Q24650065 | ||
| Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptors | Q24653841 | ||
| Ubiquitination regulates proteolytic processing of G protein-coupled receptors after their sorting to lysosomes | Q24657919 | ||
| Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling | Q28239433 | ||
| Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling | Q28268819 | ||
| N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells | Q28283150 | ||
| GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits | Q28286818 | ||
| Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation | Q28290869 | ||
| Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH‐SY5Y cells | Q28344890 | ||
| Cellular regulation of RGS proteins: modulators and integrators of G protein signaling | Q28646133 | ||
| Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors | Q31816606 | ||
| Cannabinoid-opioid interactions during neuropathic pain and analgesia | Q33637224 | ||
| RGS4 and RGS5 are in vivo substrates of the N-end rule pathway | Q34085136 | ||
| Regulators of G-protein signalling as new central nervous system drug targets. | Q34139169 | ||
| Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Galpha subtype dependent | Q34162653 | ||
| Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot | Q34701089 | ||
| G protein independent phosphorylation and internalization of the delta-opioid receptor | Q35212944 | ||
| Isoforms of mammalian adenylyl cyclase: multiplicities of signaling | Q35679436 | ||
| Regulators of G protein signaling & drugs of abuse. | Q36056317 | ||
| Sensitization of adenylate cyclase by Galpha i/o-coupled receptors | Q36142386 | ||
| Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies | Q36741486 | ||
| Signaling by internalized G-protein-coupled receptors. | Q37715118 | ||
| Ubiquitin, proteasomes, and the regulation of intracellular protein degradation | Q40445002 | ||
| Differentially Regulated Expression of Endogenous RGS4 and RGS7 | Q40618796 | ||
| Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies | Q40955606 | ||
| delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells | Q41249441 | ||
| Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line | Q41328527 | ||
| Adenylyl cyclase in SH-SY5Y human neuroblastoma cells is regulated by intra- and extracellular calcium. | Q41343549 | ||
| RGS4 is arginylated and degraded by the N-end rule pathway in vitro | Q41732590 | ||
| Stoichiometries of AMPA receptor subunit mRNAs in rat brain fall into discrete categories | Q42444499 | ||
| Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart | Q42544516 | ||
| Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia | Q42601949 | ||
| Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. | Q43744848 | ||
| Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned mu- or kappa-opioid receptors | Q43832333 | ||
| Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment | Q44149282 | ||
| Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine | Q44327442 | ||
| Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation | Q44342223 | ||
| Opioid receptors in human neuroblastoma SH-SY5Y cells: evidence for distinct morphine (mu) and enkephalin (delta) binding sites | Q44346951 | ||
| Regulation of RGS proteins by chronic morphine in rat locus coeruleus | Q44373732 | ||
| Differential coupling of muscarinic receptors to Ca2+ mobilization and cyclic AMP in SH-SY5Y and IMR 32 neuroblastoma cells | Q44652721 | ||
| Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time | Q44847937 | ||
| RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis | Q46050875 | ||
| Chronic cocaine reduces RGS4 mRNA in rat prefrontal cortex and dorsal striatum | Q48104056 | ||
| Drug effects in a radial maze designed for dissociation of cues used by mice. | Q52216974 | ||
| Bradykinin-evoked release of [3H]noradrenaline from the human neuroblastoma SH-SY5Y. | Q52871526 | ||
| RGS Proteins Determine Signaling Specificity of Gq-coupled Receptors | Q60687223 | ||
| Identification of alpha 2-adrenergic receptor sites in human retinoblastoma (Y-79) and neuroblastoma (SH-SY5Y) cells | Q69331646 | ||
| Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY5Y and SH-EP1 | Q69697029 | ||
| Rapid kinetics of regulator of G-protein signaling (RGS)-mediated Galphai and Galphao deactivation. Galpha specificity of RGS4 AND RGS7 | Q74172895 | ||
| The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling | Q77696554 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| protein ubiquitination | Q3547638 | ||
| P304 | page(s) | 7854-7864 | |
| P577 | publication date | 2011-01-05 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk | |
| P478 | volume | 286 |
| Q36115328 | A finer tuning of G-protein signaling through regulated control of RGS proteins |
| Q43509575 | Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment. |
| Q35814106 | Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway |
| Q38049934 | Endogenous opiates and behavior: 2011 |
| Q64065904 | Interplay between the Endogenous Opioid System and Proteasome Complex: Beyond Signaling |
| Q34251193 | MEKK1-MKK4-JNK-AP1 Pathway Negatively Regulates Rgs4 Expression in Colonic Smooth Muscle Cells |
| Q36573196 | Modulation of μ-Opioid Receptor Signaling by RGS19 in SH-SY5Y Cells |
| Q37279348 | Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner |
| Q38960056 | RGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway. |
| Q40074769 | RGS4 Overexpression in Lung Attenuates Airway Hyper-responsiveness in Mice |
| Q41869073 | RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm |
| Q30541823 | Rab Family Proteins Regulate the Endosomal Trafficking and Function of RGS4 |
| Q47637709 | Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins |
| Q35523846 | Regulators of G Protein Signaling (RGS) Proteins as Drug Targets: Modulating G-Protein-Coupled Receptor (GPCR) Signal Transduction |
| Q37665104 | Role of regulator of G protein signaling proteins in bone. |
| Q27011348 | Roles of the ubiquitin proteasome system in the effects of drugs of abuse |
| Q41470342 | Small Molecule Inhibitors of Regulator of G Protein Signalling (RGS) Proteins |
| Q38736977 | The delta opioid receptor tool box. |
| Q26991859 | μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: From a symposium on new concepts in mu-opioid pharmacology |
Search more.